Telehealth sees rising off-label use of GLP-1s for substance abuse
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Biological age test to steer GLP-1 prescriptions
Deep Longevity’s new US telehealth platform, Accrua, ties treatment plans to a blood-based aging score and re-tests every…
Eli Lilly, NIH grants, Novartis, Regeneron: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
Petwealth Uses AI to Turn Pet Lab Results Into Action
Angelo Palivos built Petwealth after losing his own pet to an illness that a diagnostic lab couldn’t catch…
GLP-1 drug prescribed to woman with eating disorder via telehealth sparks calls for regulation
Experts are calling for greater oversight of telehealth clinics after an online clinic prescribed injectable weight-loss medications to…
Secret shopper study reveals questionable telehealth GLP-1 practices
Katie covers the impact of health technology on patients, clinicians, and businesses. Her stories explore the price tag…
Legal fights brewing over the basic business model of telehealth
In less than a decade, telehealth has expanded from a sideshow of health care to an industry worth…
How Hims has transformed medicine in a few short years
As the Super Bowl approached halftime, Hims & Hers publicly staked its claim to preventive medicine in front…
Media Watch targets Dr Nick Coatsworth for ‘disclosure failures’ after promoting GLP-1 receptor agonists on TV
Dr Nick Coatsworth has come under fire for promoting GLP-1 receptor agonist medications on television without consistently disclosing that…
Telehealth ketamine companies put users at risk
Telehealth companies are mailing a Schedule III narcotic to tens of thousands of depressed patients, hailing it as…
Blackbird-backed telehealth startup Eucalyptus sells for $1.6 billion to US listed rival
Australian online healthcare startup Eucalyptus is being acquired by NYSE-listed health and wellness rival Hims & Hers Health…
MangoRx $99 TRT sales jump 336%, CAC down 54%
Mangoceuticals (NASDAQ: MGRX) reported early traction for a newly launched all-inclusive injectable Testosterone…